ClinicalTrials.gg
CompletedNCT02315963Updated Feb 1, 2021

Feedback and Rewards to Increase Motivation for Therapy in Stroke Rehabilitation

An interventional study of Performance Feedback in Stroke, sponsored by Cereneo AG. Completed at 1 site in Switzerland. Per ClinicalTrials.gov, last updated 2021-02-01.

Sponsored by Cereneo AG · Not applicable, Interventional, and Health services research

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
62
Allocation
Non-randomized
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 216 studies in Stroke with a site in Switzerland — 46 open to participants now, 60 under way, 6 of them phase 3. Stroke · Switzerland.

Planned enrollment
80th of 147
62 · median 79
Started
2016
with 9 others
No phase
95 of 216
24 open now
Registered
70th of 216
by date
Lead sponsor
6 of 216
Cereneo AG

Among the 216 studies in Stroke with a site in Switzerland, this one is the 80th largest by planned enrollment of the 147 interventional ones that give a count, is one of 10 that started in 2016, is one of 95 with no phase, and was the 70th registered.

Stroke

8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.

Browse Stroke studies →

Open to participants now

46 of the 216 studies in Stroke with a site in Switzerland are open now. Recruiting first, the newest first:

41 more — sign in →

All 46 open studies →

A study can be open while its sites in Switzerland have not opened yet or have stopped. Only those recruiting at a site in Switzerland →

Who these studies take

Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.

This study: all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 216 studies in Stroke with a site in Switzerland, or all of them as a file.
02

Study summary

High motivation is a predictor for good therapy results in physical therapy [Grahn 2000]. The investigator want to show that it is possible to increase patients motivation for stroke rehabilitation by providing them objective performance feedback about the patients therapy progress.

Read the detailed description

High motivation is a predictor for good therapy results in physical therapy [Grahn 2000]. Additional focus on motivation and rewards has fallen on the topic of stroke rehabilitation since it was shown in an animal model that the brain centers involved with motivation and rewards are crucial to motor learning [Hosp 2011].

The investigators goal is to target the overall motivation for therapy. During the guided therapy sessions the therapists will be the main motivators and the investigators do not want to interfere with that. But the amount of guided therapy sessions is often limited due to economical reason rather than therapeutic ones. Therefore patients are encouraged to do training on their own if possible and to be active during the patients stay in the rehabilitation clinic. The investigators target the patients motivation to train by themselves and be active but also the patients attitude towards the guided therapies. It is known that performance feedback can improve motivation [Harackiewicz 1979]. Therefore the investigators want to use the data about therapy progress to produce feedback for patients visualizing the patients progress and efforts during the patients stay in the clinic.

The investigators will compare patients who receive normal therapy to patients who receive normal therapy plus performance feedback regarding a variety of motivation measures.

03

Conditions studied

  • Stroke

Browse trials for

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • First time Inpatient at the Cereneo rehabilitation clinic

Exclusion criteria

Exclusion Criteria:

  • Rey-Figur Kopie \<= 25 AND Rechnerisches Denken WIE \<=5
  • Becks Depression Inventar (BDI) > 17
  • Major aphasia preventing understanding of study materials (according to the treating physician).
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
62 participants (estimated)

Study arms

  • No intervention
    No intervention group

    Patients in stroke rehabilitation receiving standard therapy

  • Active comparator
    Intervention group

    Patients in stroke rehabilitation receiving standard therapy plus performance feedback

    Other: Performance Feedback

Interventions

  • OtherPerformance Feedback

    Performance Feedback regarding the patients efforts and accomplishments during the patients stay in the rehabilitation clinic, an expected average of 6 weeks. The data available about the patients progress will be analysed and processed to create a visual illustration shown to the patient on a daily bases.

06

What researchers measure

Primary outcomes

  1. Motivation

    Weekly: Intrinsic Motivation Inventory Questionnaire

    Time frame: Weekly for the duration of the participants stay at the hospital an expected average of 6 weeks

  2. Motivation

    Motivation rating of patients regarding the foregoing therapy session by therapists

    Time frame: After each therapy session for the duration of the participants stay at the hospital an expected average of 6 weeks

  3. Motivation

    Time patient spends on self administered training

    Time frame: Continuous for the duration of the participants stay at the hospital an expected average of 6 weeks

  4. Motivation

    Amount of activities (walking, stair climbing) during free time

    Time frame: Continuousfor the duration of the participants stay at the hospital an expected average of 6 weeks

Secondary outcomes

  1. Clinical scores (e.g. Fugl-Meyer Score)

    Standard quality assessments of the study site (rehabilitation clinic)

    Time frame: When decided by therapists for the duration of the participants stay at the hospital an expected average of 6 weeks

07

Study locations

1 site
  • Cereneo, Center For Rehabilitation and Neurology
    Vitznau, Lucerne 6354, Switzerland
08

References and documents

Publications

  • Grahn B, Ekdahl C, Borgquist L. Motivation as a predictor of changes in quality of life and working ability in multidisciplinary rehabilitation. A two-year follow-up of a prospective controlled study in patients with prolonged musculoskeletal disorders. Disabil Rehabil. 2000 Oct 15;22(15):639-54. doi: 10.1080/096382800445443. PubMed 11087060 ↗
  • Hosp JA, Pekanovic A, Rioult-Pedotti MS, Luft AR. Dopaminergic projections from midbrain to primary motor cortex mediate motor skill learning. J Neurosci. 2011 Feb 16;31(7):2481-7. doi: 10.1523/JNEUROSCI.5411-10.2011. PubMed 21325515 ↗
  • Harackiewicz, Judith M. The effects of reward contingency and performance feedback on intrinsic motivation. Journal of Personality and Social Psychology, Vol 37(8), Aug 1979, 1352-1363.
09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Apr 2016, a primary completion of Dec 2020 and a completion of Dec 2020. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 8, 2014
First posted
Dec 12, 2014
Start
Apr 2016
Primary completionActual
Dec 2020
CompletionActual
Dec 2020
Last update
Feb 1, 2021
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 1, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02315963
Lead sponsor
Cereneo AG
Responsible party
Sponsor
First posted
Dec 12, 2014
Start date
Apr 2016
Primary completion
Dec 2020
Completion
Dec 2020
Last update
Feb 1, 2021

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion